In Non-small cell lung cancer (NSCLC), it acts as a tumor suppressor, inducing senescence via SMAD3 interaction and repressing cell cycle regulators such as CDK1 and CCNE2. Here, SMAD3 is linked to non-small cell lung carcinoma.